Company / Accounts Receivable
INSMED Inc Accounts Receivable History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$140.9M
FY2025
5-year range
$24.4M / $140.9M
FY2021-FY2025
Trend
+170.8%
vs FY2024
Sector context
#41 of 113
Health Care
What the data says
At $141M, INSMED Inc's accounts receivable ranks #41 of 113 in the Health Care sector. Accounts Receivable has increased for 5 consecutive years, from $17M in FY2020 to $141M in FY2025.
Based on SEC 10-K filings.
$141M in FY2025 with a 5-year CAGR of +53.4%.
Improved from $41M to $141M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +68.0%
- 5-Year CAGR
- +53.4%
- 10-Year CAGR
- -
Sector benchmark
#41 of 113 in Health CareTop 36% of 113This company $140.9M Sector average $1.1B
▼
-87.6% below sector average
Key checks
Key Insights
- INSMED Inc's accounts receivable has grown for 5 consecutive years.
- 5-year CAGR of +53.4%, indicating consistent growth.
- In FY2025, accounts receivable increased 170.8% year-over-year.
- Ranks #41 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -2.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $140.9M | +170.8% |
| FY2024 | $52.0M | +26.3% |
| FY2023 | $41.2M | +38.6% |
| FY2022 | $29.7M | +22.0% |
| FY2021 | $24.4M | +47.0% |
| FY2020 | $16.6M | -13.9% |
| FY2019 | $19.2M | +248.7% |
| FY2018 | $5.5M | - |
| FY2017 | $0 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026